We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.54%
AUM
$110B
AUM Growth
+$9.81B
Cap. Flow
+$7.5B
Cap. Flow %
6.8%
Top 10 Hldgs %
20.07%
Holding
4,881
New
700
Increased
2,284
Reduced
1,341
Closed
315

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.17%
2 Financials 9.94%
3 Technology 9.55%
4 Energy 8.42%
5 Healthcare 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIT icon
2601
Harmonic Inc
HLIT
$1.2B
$1.89M ﹤0.01%
256,413
-41,680
-14% -$309K
ARNA
2602
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.89M ﹤0.01%
+32,350
New +$1.69M
YELL
2603
DELISTED
Yellow Corporation Common Stock
YELL
$1.89M ﹤0.01%
108,812
+49,647
+84% +$596K
SZYM
2604
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$1.89M ﹤0.01%
173,242
-84,434
-33% -$831K
DAKT icon
2605
Daktronics
DAKT
$839M
$1.89M ﹤0.01%
120,317
+82,766
+220% +$1.1M
AMAG
2606
DELISTED
AMAG Pharmaceuticals
AMAG
$1.89M ﹤0.01%
77,700
+33,311
+75% +$783K
EZPW icon
2607
Ezcorp Inc
EZPW
$1.94B
$1.88M ﹤0.01%
160,850
+111,950
+229% +$1.49M
LAB icon
2608
Standard BioTools
LAB
$287M
$1.88M ﹤0.01%
49,118
+34,604
+238% +$1.02M
AIRM
2609
DELISTED
Air Methods Corp
AIRM
$1.88M ﹤0.01%
32,278
+550
+2% +$27.4K
DYAX
2610
DELISTED
DYAX CORPORATION
DYAX
$1.88M ﹤0.01%
249,104
+186,500
+298% +$1.42M
SCHH icon
2611
Schwab US REIT ETF
SCHH
$11B
$1.88M ﹤0.01%
123,960
+10,148
+9% +$158K
HITT
2612
DELISTED
HITTITE MICROWAVE CORP
HITT
$1.87M ﹤0.01%
30,344
+16,909
+126% +$1.06M
ARC
2613
DELISTED
ARC Document Solutions, Inc.
ARC
$1.87M ﹤0.01%
227,649
+167,209
+277% +$1.2M
SHPG
2614
DELISTED
Shire pic
SHPG
$1.87M ﹤0.01%
13,249
-1,272
-9% -$167K
PDI icon
2615
PIMCO Dynamic Income Fund
PDI
$6.9B
$1.87M ﹤0.01%
64,200
-22,800
-26% -$667K
AMD icon
2616
CALL
Advanced Micro Devices
AMD
$890B
$1.87M ﹤0.01%
482,200
-2,405,800
-83% -$8.63M
NWG icon
2617
NatWest
NWG
$75.2B
$1.87M ﹤0.01%
152,943
-131,762
-46% -$1.58M
TPLM
2618
DELISTED
Triangle Petroleum Corporation
TPLM
$1.87M ﹤0.01%
224,343
+97,483
+77% +$990K
ENOV icon
2619
Enovis
ENOV
$1.03B
$1.86M ﹤0.01%
17,006
-3,459
-17% -$346K
RGS icon
2620
Regis Corp
RGS
$68.2M
$1.86M ﹤0.01%
6,422
+1,899
+42% +$571K
VGIT icon
2621
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.3B
$1.86M ﹤0.01%
29,746
-3,366
-10% -$214K
FCRD
2622
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$1.86M ﹤0.01%
112,987
+40,537
+56% +$661K
RAS
2623
DELISTED
RAIT Financial Trust
RAS
$1.86M ﹤0.01%
207,721
+39,849
+24% +$311K
TTI icon
2624
TETRA Technologies
TTI
$911M
$1.86M ﹤0.01%
150,564
+63,159
+72% +$787K
AIT icon
2625
Applied Industrial Technologies
AIT
$11.6B
$1.86M ﹤0.01%
37,891
-12,644
-25% -$616K

Similar funds

Credit Suisse's Q4 2013 Portfolio in Review

As of Q4 2013, Credit Suisse held 4,881 positions worth $110B, up 9.8% from $101B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse deployed $7.5B of net new capital in Q4 2013, opening 700 new positions and adding to 2,284 existing holdings. Its largest new stake was Deutsche Bank: 9,817,335 shares worth $403M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 41% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B trimmed.

  • Credit Suisse's largest Q4 2013 buy was Deutsche Bank: 9,817,335 shares worth $403M.
  • Credit Suisse added most to Elevance Health in Q4 2013, an estimated $191M increase.
  • Credit Suisse's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
  • Credit Suisse fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $231M.
  • Credit Suisse's ten largest holdings make up 20% of its $110B portfolio in Q4 2013.
  • Credit Suisse opened 700 new positions and closed 315 in Q4 2013.
  • Credit Suisse's portfolio value rose 9.8% quarter-over-quarter to $110B.

Based on Credit Suisse's 13F filing for Q4 2013, filed 14 Feb 2014.